GLOBAL HEALTH & HEART

GLOBAL HEALTH & HEART GLOBAL HEALTH & HEART GLOBAL HEALTH & HEART

GLOBAL HEALTH & HEART

GLOBAL HEALTH & HEART GLOBAL HEALTH & HEART GLOBAL HEALTH & HEART
  • HOME
  • WHAT WE DO
  • MEDIA
  • RESOURCES
  • CONTACT US
  • More
    • HOME
    • WHAT WE DO
    • MEDIA
    • RESOURCES
    • CONTACT US
  • Sign In
  • Create Account

  • Orders
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Orders
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • HOME
  • WHAT WE DO
  • MEDIA
  • RESOURCES
  • CONTACT US

Account


  • Orders
  • My Account
  • Sign out


  • Sign In
  • Orders
  • My Account

Global Health Research Foundation

ALZHEIMER'S DISEASE RESEARCH

The Effect of an Aloe Polymannose Multinutrient Complex on Alzheimer's Disease

 

 [Clinical Trial Published in  the  Journal of  Alzheimers Disease]

     

 The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in Alzheimer's disease  

         

  John E Lewis,  H Reginald McDaniel, Marc E Agronin, David A Loewenstein, Jorge Riveros, Rafael Mestre, Mairelys Martinez, Niurka Colina, Dahlia Abreu, Janet Konefal, Judi M Woolger, Karriem H Ali               


Abstract:             


Alzheimer's disease (AD) is a leading killer of Americans, imparts  a significant toll on the quality of life of the patient and primary  caregiver, and results in inordinate costs in an already overburdened  medical system. Prior studies on cholinesterase inhibitors among AD  patients have shown minimal amelioration of disease symptoms and/or  restoration of lost cognitive functioning. The effect of improved  nutrition, particularly with dietary supplements, on cognitive  functioning may offer an alternative strategy compared to standard  treatment. The present pilot study investigated the effect of an aloe  polymannose multinutrient complex (APMC) formula on cognitive and immune  functioning over 12 months among adults diagnosed with AD. Subjects  participated in an open-label trial and consumed 4 teaspoons per day of  the APMC. The ADAS-cog, MMSE, ADCS-ADL, and SIB were administered at  baseline and 3, 6, 9, and 12 months follow-up. Cytokines and lymphocyte  and monocyte subsets were assessed at baseline and 12 months. The mean  ADAS-cog cognition score significantly improved at 9 and 12 months from  baseline, and 46% of our sample showed clinically-significant  improvement (≥4-point change) from baseline to 12 months. Participants  showed significant decreases in tumor necrosis factor-α, vascular  endothelial growth factor, and interleukins-2 and-4. CD90+, CD95+CD3+,  CD95+CD34+, CD95+CD90+, CD14+CD34+, CD14+CD90+, and CD14+CD95+ decreased  significantly, whereas CD14+ significantly increased. Participants  tolerated the APMC supplement with few, temporary adverse reactions. Our  results showed improvements in both clinical and physiological outcomes  for a disease that otherwise has no standard ameliorative remedy.     


       Similar articles       

  •                Relationship between brain-derived neurotrophic factor and  immune function during dietary supplement treatment of elderly with  Alzheimer's dementia.              Stillman J, Martin A, Miguez MJ, McDaniel HR, Konefal J, Woolger JM, Lewis JE. J Clin Transl Res. 2020 Jan 29;5(2):68-75. eCollection 2020 Jan 29. PMID: 32377581 Free PMC article.   
  •                Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine.              Bullock R, Erkinjuntti T, Lilienfeld S; GAL-INT-6 Study Group. Dement Geriatr Cogn Disord. 2004;17(1-2):29-34. doi: 10.1159/000074140. Epub 2003 Oct 13. PMID: 14560062 Clinical Trial.   
  •                A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.              Chu LW, Yik PY, Mok W, Chung CP. Int J Clin Pract. 2007 Mar;61(3):403-10. doi: 10.1111/j.1742-1241.2007.01284.x. PMID: 17313606 Clinical Trial.   
  •                A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease.              Stein MS, Scherer SC, Ladd KS, Harrison LC. J Alzheimers Dis. 2011;26(3):477-84. doi: 10.3233/JAD-2011-110149. PMID: 21694461 Clinical Trial.   
  •                The effect of dietary supplementation on brain-derived  neurotrophic factor and cognitive functioning in Alzheimer's dementia.              Martin A, Stillman J, Miguez MJ, McDaniel HR, Konefal J, Woolger JM, Lewis JE. J Clin Transl Res. 2017 Dec 3;3(3):337-343. eCollection 2018 Jan 15. PMID: 30895275 Free PMC article.   

      See all similar articles         

       Cited by       

  •                Polysaccharides from aloe vera target the Wnt/β-catenin pathway to impact the tooth density of pulpitis rats.              Jiang L, Lu Y, Zhao H, He W. Acta Cir Bras. 2023 Jan 13;37(12):e371202. doi: 10.1590/acb371202. eCollection 2023. PMID: 36651427 Free PMC article.   
  •                Aloe vera and Fermented Extracts Exhibit an Anti-Inflammatory Effect on Human Glioblastoma/Astrocytoma U373 MG Cells.              Tornero-Martínez A, Del Carmen Silva-Lucero M, Sampedro EC, Ramón-Gallegos E, Pérez-Cruz C, Pérez-Grijalva B, Mora-Escobedo R. Plant Foods Hum Nutr. 2022 Mar;77(1):37-43. doi: 10.1007/s11130-022-00957-4. Epub 2022 Mar 15. PMID: 35292934   
  •                The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.              Lewis JE, Poles J, Shaw DP, Karhu E, Khan SA, Lyons AE, Sacco SB, McDaniel HR. J Clin Transl Res. 2021 Aug 4;7(4):575-620. eCollection 2021 Aug 26. PMID: 34541370 Free PMC article. Review.   
  •                The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.              Poles J, Karhu E, McGill M, McDaniel HR, Lewis JE. J Clin Transl Res. 2021 May 27;7(3):333-376. eCollection 2021 Jun 26. PMID: 34239993 Free PMC article. Review.   
  •                Relationship between brain-derived neurotrophic factor and  immune function during dietary supplement treatment of elderly with  Alzheimer's dementia.              Stillman J, Martin A, Miguez MJ, McDaniel HR, Konefal J, Woolger JM, Lewis JE. J Clin Transl Res. 2020 Jan 29;5(2):68-75. eCollection 2020 Jan 29. PMID: 32377581 

RESOURCES

PHILANTHROPY, HEALTH & YOU !

 

PHILANTHROPY, HEALTH, AND YOU

Catherine Zimmer states that, “The purpose of philanthropy is to improve the well-being of humankind by preventing and solving social problems.  

READ MORE

Copyright © 2025 GHH - All Rights Reserved.

Powered by GoDaddy

  • HOME
  • WHAT WE DO
  • MEDIA
  • RESOURCES
  • CONTACT US

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept